These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 20590833)
21. Adenosine A1 and A2A receptors of hippocampal CA1 region have opposite effects on piriform cortex kindled seizures in rats. Zeraati M; Mirnajafi-Zadeh J; Fathollahi Y; Namvar S; Rezvani ME Seizure; 2006 Jan; 15(1):41-8. PubMed ID: 16337818 [TBL] [Abstract][Full Text] [Related]
22. [Positron emission tomography: contribution to diagnosis of dementia and development of disease-modifying drugs]. Ito K; Kato T Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Aug; 29(4):153-60. PubMed ID: 19764482 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of [4-O-methyl-(11)C]KW-6002 as a potential PET ligand for mapping central adenosine A(2A) receptors in rats. Hirani E; Gillies J; Karasawa A; Shimada J; Kase H; Opacka-Juffry J; Osman S; Luthra SK; Hume SP; Brooks DJ Synapse; 2001 Dec; 42(3):164-76. PubMed ID: 11746713 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of individual skeletal muscle activity by glucose uptake during pedaling exercise at different workloads using positron emission tomography. Gondoh Y; Tashiro M; Itoh M; Masud MM; Sensui H; Watanuki S; Ishii K; Takekura H; Nagatomi R; Fujimoto T J Appl Physiol (1985); 2009 Aug; 107(2):599-604. PubMed ID: 19541734 [TBL] [Abstract][Full Text] [Related]
25. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. Vallabhajosula S Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348 [TBL] [Abstract][Full Text] [Related]
26. Neural correlates of the Clock Drawing Test performance in Alzheimer's disease: a FDG-PET study. Lee DY; Seo EH; Choo IH; Kim SG; Lee JS; Lee DS; Jhoo JH; Kim KW; Youn JC; Woo JI Dement Geriatr Cogn Disord; 2008; 26(4):306-13. PubMed ID: 18841015 [TBL] [Abstract][Full Text] [Related]
27. Roles of adenosine A1 and A2A receptors in the control of micturition in rats. Kitta T; Chancellor MB; de Groat WC; Kuno S; Nonomura K; Yoshimura N Neurourol Urodyn; 2014 Nov; 33(8):1259-65. PubMed ID: 24014261 [TBL] [Abstract][Full Text] [Related]
28. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. Dukart J; Mueller K; Horstmann A; Vogt B; Frisch S; Barthel H; Becker G; Möller HE; Villringer A; Sabri O; Schroeter ML Neuroimage; 2010 Jan; 49(2):1490-5. PubMed ID: 19770055 [TBL] [Abstract][Full Text] [Related]
29. Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease. Dubois A; Hérard AS; Delatour B; Hantraye P; Bonvento G; Dhenain M; Delzescaux T Neuroimage; 2010 Jun; 51(2):586-98. PubMed ID: 20206704 [TBL] [Abstract][Full Text] [Related]
30. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography. Koeppe RA; Gilman S; Junck L; Wernette K; Frey KA Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S67-76. PubMed ID: 18632004 [TBL] [Abstract][Full Text] [Related]
31. Simultaneous demonstration of metabolic lesions consistent with Alzheimer disease and brain metastases on FDG-PET imaging. Takalkar AM; El-Haddad G; Lilien DL; Patterson JC Clin Nucl Med; 2008 Jun; 33(6):438-40. PubMed ID: 18496460 [No Abstract] [Full Text] [Related]
32. Positron emission tomography imaging in dementia. Herholz K; Carter SF; Jones M Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746 [TBL] [Abstract][Full Text] [Related]
33. Cell-specific differential modulation of human trabecular meshwork cells by selective adenosine receptor agonists. Karl MO; Peterson-Yantorno K; Civan MM Exp Eye Res; 2007 Jan; 84(1):126-34. PubMed ID: 17070802 [TBL] [Abstract][Full Text] [Related]
34. Development of [18F]-labeled pyrazolo[4,3-e]-1,2,4- triazolo[1,5-c]pyrimidine (SCH442416) analogs for the imaging of cerebral adenosine A2A receptors with positron emission tomography. Khanapur S; Paul S; Shah A; Vatakuti S; Koole MJ; Zijlma R; Dierckx RA; Luurtsema G; Garg P; van Waarde A; Elsinga PH J Med Chem; 2014 Aug; 57(15):6765-80. PubMed ID: 25061687 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of [11C]FR194921 as a nonxanthine-type PET tracer for adenosine A1 receptors in the brain. Matsuya T; Takamatsu H; Murakami Y; Noda A; Ichise R; Awaga Y; Nishimura S Nucl Med Biol; 2005 Nov; 32(8):837-44. PubMed ID: 16253808 [TBL] [Abstract][Full Text] [Related]
37. Effect of aging on cerebral A1 adenosine receptors: A [18F]CPFPX PET study in humans. Meyer PT; Elmenhorst D; Boy C; Winz O; Matusch A; Zilles K; Bauer A Neurobiol Aging; 2007 Dec; 28(12):1914-24. PubMed ID: 16996650 [TBL] [Abstract][Full Text] [Related]
38. Validating the DemTect with 18-fluoro-2-deoxy-glucose positron emission tomography as a sensitive neuropsychological screening test for early alzheimer disease in patients of a memory clinic. Scheurich A; Muller MJ; Siessmeier T; Bartenstein P; Schmidt LG; Fellgiebel A Dement Geriatr Cogn Disord; 2005; 20(5):271-7. PubMed ID: 16158009 [TBL] [Abstract][Full Text] [Related]
39. 3,4-dihydroxy-6-[18f]-fluoro-L-phenylalanine positron emission tomography in patients with central motor disorders and in evaluation of brain and other tumors. Seibyl JP; Chen W; Silverman DH Semin Nucl Med; 2007 Nov; 37(6):440-50. PubMed ID: 17920351 [TBL] [Abstract][Full Text] [Related]